Literature DB >> 15136712

Clinical characteristics of responders to interferon therapy for relapsing MS.

Pablo Villoslada, Jorge R Oksenberg, Jordi Rio, Xavier Montalban.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15136712     DOI: 10.1212/wnl.62.9.1653

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

Review 1.  Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities.

Authors:  Zohara Sternberg
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

Review 2.  Predicting responders to therapies for multiple sclerosis.

Authors:  Jordi Río; Manuel Comabella; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2009-10       Impact factor: 42.937

3.  Transient oscillatory dynamics of interferon beta signaling in macrophages.

Authors:  Inna Pertsovskaya; Elena Abad; Núria Domedel-Puig; Jordi Garcia-Ojalvo; Pablo Villoslada
Journal:  BMC Syst Biol       Date:  2013-07-09

4.  Relapsing-remitting multiple sclerosis: patterns of response to disease-modifying therapies and associated factors: a national survey.

Authors:  Maria José Sá; João de Sá; Lívia Sousa
Journal:  Neurol Ther       Date:  2014-09-03

5.  Long-term use of interferon-β in multiple sclerosis increases Vδ1-Vδ2-Vγ9- γδ T cells that are associated with a better outcome.

Authors:  Guzailiayi Maimaitijiang; Mitsuru Watanabe; Koji Shinoda; Noriko Isobe; Yuri Nakamura; Katsuhisa Masaki; Takuya Matsushita; Yasunobu Yoshikai; Jun-Ichi Kira
Journal:  J Neuroinflammation       Date:  2019-09-13       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.